CDSCO

The Central Drugs Standard Control Organization (CDSCO) has released a draft guidance document on the conduct and regulation of…

The pen will be available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing healthcare…

Dr Jay Goyal, Eye Surgeon, LASIK specialist, Retina Specialist, and Director, Surya Eye Hospital, sheds light on India’s…

The trial evaluates the safety and efficacy of Eyecyte-RPE in patients with geographic atrophy secondary to dry age-related…

Industry experts from India’s medical devices sector have responded with a mix of optimism and caution to the recently announced…

State FDA, Karnataka, clears Medios HI Glaucoma AI and Medios HI AMD AI for nationwide use, expanding access to early detection…

SS Innovations International reported revenues reaching $20.6 million for the year ending December 31, 2024, rising by 40.9 % from…

The existing method has been upgraded to a new functional online system, prompting manufacturers to re-submit fresh MSC and NCC…

All concerned associations/stakeholders are requested to forward their comments within 30 days of the publication of this draft…

Many industry experts welcome the move, while others, emphasise the need for an expedited policy framework to minimise disruption